Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
暂无分享,去创建一个
B. Neustadt | L. Armstrong | C. Kumar | M. Malkowski | Z. Yin | M. Presta | E. Tanghetti | J. Varner | B. Yaremko | T. Nechuta | M. Liu | E. M. Smith